/
Background The Company s common shares are listed on the Cboe Canada (the Cboe ) under the symbol CBST and are quoted on the OTCQX Best Market (the OTCQX ) under the symbol CBSTF and on the Frankfurt Stock Exchange under the symbol 3LP . The Company s principal business activity is the production and sale of cannabis as regulated by the regulatory bodies and authorities of the jurisdictions in …
$0.00
$0.00 (-50.00%)
EOD Jul 17, 2026
The business is unprofitable at the operating level (-4.80% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 9.9% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -$29M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$355M
▼ -9.9% YoY
Net Income (TTM)
-$179M
▲ +39.7% YoY
Op. Margin
-14.07%
▲ +15.6pp YoY
ROIC
-8.62%
▲ +8.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$37M
▼ -1070.7% YoY
Op. Cash Flow (TTM)
-$32M
▼ -412.9% YoY
Net Debt
$422M
Cash & Equiv.
$21M
3Y CAGR: +0.3%
Continue Research
Cannabist Company Holdings (CBSTQ)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Cannabist Company Holdings scores 15/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Cannabist Company Holdings scores 15 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -14.1% operating margin and a -8.6% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh CBSTQ's valuation and scores 15/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.